- This event has passed.
Update in Glomerular Disease 2025 – 14th Annual
February 7
Participants will explore the latest treatment guidelines for lupus nephritis, IgA nephropathy, ANCA vasculitis, and monoclonal gammopathy. They will understand the importance of individualized treatment plans based on disease severity, patient characteristics, and comorbidities. Participants will understand target therapies’ (including complement inhibitors, B cell targeted therapies, endothelin-angiotensin system modulators, and plasma cell therapies)